Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > New Press Release - Theralase Expands Intellectual Property Portfolio
View:
Comment by Oilminerdeluxe on Jun 28, 2022 7:22am
Something for the shareholders. Happy AGM everyone.
Comment by Legit62 on Jun 28, 2022 7:48am
Thanks Oilminer
Comment by IvanVanBeethoven on Jun 28, 2022 8:03am
Arkady Mandel, M.D., Ph.D., D.Sc., Interim Chief Executive Officer (“CEO”) and Chief Scientific Officer (“CSO”), Theralase® stated that, “This patent is strategic to opening up new international opportunities for Theralase® by expanding its IP portfolio of medical laser and oncology focused technologies internationally. Theralase®’s long-term strategy is to commercialize the Anti ...more  
Comment by Legit62 on Jun 28, 2022 8:25am
Those statements are very very positive, i said there was going to be news release this AM in previous post due to fact they have to disclose to public whats going to transpire in AGM today. We are closer than we think
Comment by ScienceFirst on Jun 28, 2022 8:32am
Only one big pharma will be able to salivate.  And it has to be faster than its competitors, given the size of the market shares, if we clearly have impressive durable response.   So it will be interesting to hear about the 270-day data for the 11 patients that had received their 180-day dose (maintenance dose) but for which their data 270-day was still pending.
Comment by Legit62 on Jun 28, 2022 8:42am
SF, are there 280 million shares outstanding? and when do you think they will post data of 180 and 270
Comment by ScienceFirst on Jun 28, 2022 9:22am
Fully diluted, we stand @285M shares.  TSO is 205M shares. They clearly hinted us May 29 about pending data regarding 11 patients that had received their 2nd dose but that didn't have their cystoscopy yet @270-days.  So 2 more months max to have all these 11 with 270-days data.  In the meantime, if we could have data on 50% of those, that could be interesting.
Comment by LaserStock29 on Jun 28, 2022 9:36am
Why hasn't Dr.Mandel completed the 'additional tox studies' he mentioned needed doing at the agm in 2019? The rest of that paragraph is word salad from 2014-15-16-17-18-19-20 and 21......... it's all the same 'medical speak'   What Dr.Mandel should be typing is the following With the research Dr.Kaspler and I collaborated on in 2017 and confirmed in 2019 ...more  
Comment by ScienceFirst on Jun 28, 2022 10:06am
Laserstock29 ... if you bought 8 years ago and that you still don't understand that running a SMB involves managing issues, opportunities, competition, long delays due to COVID-19, burn rate and priorities, then that's your problem.  By chance TLT management has not taken your advices as we would have lost opportunities like COVID-19 vaccines, etc ... and would have done a fire sale ...more  
Comment by IvanVanBeethoven on Jun 28, 2022 10:22am
Hi Lasershoes, I know you've been fed up with it for a long time. But all I can say is that exceptional things take time to blossom. It has been a bumpy road so far, especially in the last few years of crisis. So whenever I get frustrated, I tuck my case of Theralase red wine back away in the cellar, knowing it was an outstanding wine year when it was bottled, but still a bit too early to ...more  
Comment by Legit62 on Jun 28, 2022 10:51am
My table is set, the wine glasses are out, the filets are on the grill, the guests havent arrived yet(BTD and AA) but the aroma is awesome. Very soon the bottles will be uncorked and PARTY TIME!!!!!!!
Comment by Rumpl3StiltSkin on Jun 28, 2022 11:00am
Legit, you need to decant the wine, Then maybe pour those first glasses a lil bit ahead of time to let the wine breath, if needed.  But ok, I get what yur sayin'  ;-)
Comment by Legit62 on Jun 28, 2022 11:55am
HAHAHAHA, the problem with me would a little decant would end that bottles life
Comment by skys1 on Jun 28, 2022 11:38am
Legit - Terrific, toast to TLT's success before the party starts! 
Comment by Infinity on Jun 28, 2022 6:07pm
Bon appetit!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities